Marco Borderi

2.2k total citations
84 papers, 1.4k citations indexed

About

Marco Borderi is a scholar working on Emergency Medicine, Infectious Diseases and Virology. According to data from OpenAlex, Marco Borderi has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Emergency Medicine, 49 papers in Infectious Diseases and 37 papers in Virology. Recurrent topics in Marco Borderi's work include HIV-related health complications and treatments (54 papers), HIV/AIDS drug development and treatment (40 papers) and HIV Research and Treatment (37 papers). Marco Borderi is often cited by papers focused on HIV-related health complications and treatments (54 papers), HIV/AIDS drug development and treatment (40 papers) and HIV Research and Treatment (37 papers). Marco Borderi collaborates with scholars based in Italy, United States and Australia. Marco Borderi's co-authors include Maria Carla Re, Davide Gibellini, Pierluigi Viale, Leonardo Calza, Elisa De Crignis, Fabio Vescini, Isabella Bon, Vincenzo Colangeli, Laura Cimatti and Roberto Manfredi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.

In The Last Decade

Marco Borderi

83 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Borderi Italy	21	803	650	505	317	181	84	1.4k
Elly A. Hassink Netherlands	17	332 0.4×	368 0.6×	292 0.6×	44 0.1×	92 0.5×	31	994
Nicola Squillace Italy	18	613 0.8×	525 0.8×	306 0.6×	17 0.1×	346 1.9×	71	1.2k
M Partisani France	9	1.1k 1.4×	904 1.4×	768 1.5×	15 0.0×	144 0.8×	14	1.4k
Caryn G. Morse United States	17	208 0.3×	231 0.4×	122 0.2×	109 0.3×	327 1.8×	36	805
Álvaro H. Borges Denmark	13	481 0.6×	424 0.7×	336 0.7×	5 0.0×	233 1.3×	37	936
Pere Domingo Spain	12	217 0.3×	204 0.3×	153 0.3×	10 0.0×	181 1.0×	31	598
Paola Zangari Italy	12	161 0.2×	257 0.4×	244 0.5×	4 0.0×	188 1.0×	29	638
Ángel M. Mayor Puerto Rico	16	91 0.1×	152 0.2×	63 0.1×	10 0.0×	146 0.8×	59	796
Naoki Yanagisawa Japan	11	123 0.2×	170 0.3×	66 0.1×	5 0.0×	114 0.6×	63	435
Lourdes Mateo Spain	17	43 0.1×	151 0.2×	13 0.0×	141 0.4×	167 0.9×	88	860

Countries citing papers authored by Marco Borderi

Since Specialization

Citations

This map shows the geographic impact of Marco Borderi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Borderi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Borderi more than expected).

Fields of papers citing papers by Marco Borderi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Borderi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Borderi. The network helps show where Marco Borderi may publish in the future.

Co-authorship network of co-authors of Marco Borderi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Borderi. A scholar is included among the top collaborators of Marco Borderi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Borderi. Marco Borderi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calza, Leonardo, Marco Borderi, Vincenzo Colangeli, et al.. (2020). Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir. AIDS Research and Human Retroviruses. 37(3). 204–206. 6 indexed citations

Calza, Leonardo, et al.. (2020). Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. AIDS Research and Human Retroviruses. 37(1). 11–15. 1 indexed citations

Calza, Leonardo, Michele Sachs, Vincenzo Colangeli, et al.. (2019). Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy. Clinical and Experimental Nephrology. 23(11). 1272–1279. 12 indexed citations

Galli, Laura, Vincenzo Spagnuolo, Alba Bigoloni, et al.. (2016). Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial. Journal of Antimicrobial Chemotherapy. 71(6). 1637–1642. 7 indexed citations

Mazzotta, Elena, Tamara Ursini, Ennio Polilli, et al.. (2015). Prevalence and Predictors of Low Bone Mineral Density and Fragility Fractures Among HIV-Infected Patients at One Italian Center After Universal DXA Screening: Sensitivity and Specificity of Current Guidelines on Bone Mineral Density Management. AIDS Patient Care and STDs. 29(4). 169–180. 19 indexed citations

Pinzone, Marilia Rita, Benedetto Maurizio Celesia, Maria Gussio, et al.. (2015). Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study. Infection. 44(2). 197–203. 4 indexed citations

Gibellini, Davide, Marco Borderi, Anna Miserocchi, et al.. (2013). HIV-related mechanisms in atherosclerosis and cardiovascular diseases. Journal of Cardiovascular Medicine. 14(11). 780–790. 27 indexed citations

Focà, Emanuele, Davide Motta, Marco Borderi, et al.. (2012). Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infectious Diseases. 12(1). 38–38. 35 indexed citations

Calza, Leonardo, Roberto Manfredi, Filippo Trapani, et al.. (2012). Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. Scandinavian Journal of Infectious Diseases. 44(5). 381–387. 12 indexed citations

10.

Gibellini, Davide, Francesco Alviano, Anna Miserocchi, et al.. (2011). HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells. Retrovirology. 8(1). 40–40. 22 indexed citations

11.

Vescini, Fabio, Alessandro Cozzi‐Lepri, Marco Borderi, et al.. (2011). Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(2). 163–172. 55 indexed citations

12.

Borderi, Marco, et al.. (2009). Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical intervention.. PubMed. 32(2). 209–12. 3 indexed citations

13.

Gibellini, Davide, Marco Borderi, Elisa De Crignis, et al.. (2008). HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. Journal of Infection. 56(3). 219–225. 30 indexed citations

14.

Gibellini, Davide, Elisa De Crignis, Cristina Ponti, et al.. (2008). HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation. Journal of Medical Virology. 80(9). 1507–1514. 87 indexed citations

15.

Re, Maria Carla, Isabella Bon, Paola Monari, et al.. (2003). Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors. International Journal of Antimicrobial Agents. 22(4). 388–394. 8 indexed citations

16.

Re, Maria Carla, Paola Monari, Isabella Bon, et al.. (2002). Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz. International Journal of Antimicrobial Agents. 20(3). 223–226. 7 indexed citations

17.

Re, Maria Carla, Marco Borderi, Paola Monari, et al.. (2001). Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a cohort of Italian HIV-1 seropositive patients extensively treated with antiretroviral drugs. International Journal of Antimicrobial Agents. 18(6). 519–523. 7 indexed citations

18.

Re, Maria Carla, Paola Monari, Isabella Bon, et al.. (2001). Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients. BMC Microbiology. 1(1). 30–30. 9 indexed citations

19.

Re, Maria Carla, Eric Ramazzotti, Roberto Manfredi, et al.. (2000). Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART. Journal of Clinical Virology. 17(1). 5–11. 8 indexed citations

20.

Borderi, Marco, et al.. (1992). Anti-hepatitis C virus antibodies amongst Italian homo-bisexual males. European Journal of Epidemiology. 8(6). 804–807. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact